The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer
International Journal of Biological Sciences · 13.04.2025 · 21 (6) · 2880-2890
DOI: 10.7150/ijbs.109638 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, erschienen am 13.04.2025. Verfasst von Zhite Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Prostatic Neoplasms, Histones, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Prostate cancer (PCa) is the second most common malignant tumor in men worldwide, particularly castration-resistant prostate cancer (CRPC), for which enzalutamide (Enz) resistance is of particular concern. Modifications to histone methylation and acetylation patterns are closely associated with resistance to Enz in these patients. As PCa progresses, cancer cells alter their histone modification patterns, leading to a reduction in Enz treatment efficacy. Signaling pathways in the tumor microenvironment regulate gene expression by affecting the activity of histone-modifying enzymes, further affecting the efficacy of Enz. This review summarizes recent research about changes in histone modification patterns that occur in drug resistance-related genes at different stages of PCa and explores the potential use of combination therapies for reversing this process, providing insights into novel treatment strategies to improve the clinical efficacy of Enz.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
- The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi 710000, China.
- Department of Urology, Joint Logistics Support Force, Hospital 987, Baoji, China.
Zitieren
APA
Zhao, Z., Jing, Y., Xu, Z., Zhao, H., He, X., Lu, T., Bai, J., Qin, W., & Yang, L. (2025). The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer. International Journal of Biological Sciences, 21(6), 2880-2890. https://doi.org/10.7150/ijbs.109638
Vancouver
Zhao Z, Jing Y, Xu Z, Zhao H, He X, Lu T, et al. The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer. International Journal of Biological Sciences. 2025;21(6):2880-2890. doi:10.7150/ijbs.109638
BibTeX
@article{Zhao2025,
author = {Zhao, Zhite and Jing, Yuming and Xu, Zhicheng and Zhao, Hongfan and He, Xinglin and Lu, Tong and Bai, Jianhui and Qin, Weijun and Yang, Lijun},
title = {The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer},
journal = {International Journal of Biological Sciences},
year = {2025},
volume = {21},
number = {6},
pages = {2880--2890},
doi = {10.7150/ijbs.109638}
}
EUVIMED